Vascular Endothelial Growth Factor and Diabetic Retinopathy: Role of Oxidative Stress

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|6|4|511-524

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.4, 2005-06, pp. : 511-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-01 ,pp. : 3331-3348

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 962-968

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy

By  

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3307-3317

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Vascular Endothelial Growth Factor in Neurogenesis in Adult Brain

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-01 ,pp. : 667-669

Bentham Science Publishers

Access to resources Recommend Favorite

The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis

By  

Current Cancer Drug Targets, Vol. 12, Iss. 1, 2012-01 ,pp. : 23-43

Bentham Science Publishers

Access to resources Recommend Favorite